Analysis of chemotherapy-induced neutropenia and optimal timing for prophylactic use of G-CSF in B-cell non-Hodgkin lymphoma patients treated with R-CHOP

被引：0
|
作者：
Hisaharu Shikata
Yoshihiro Yakushijin
Jun Yamanouchi
Taichi Azuma
Masaki Yasukawa
机构：
[1] Ehime University Graduate School of Medicine,Department of Bioregulatory Medicine, Ehime University Hospital
[2] Ehime University Graduate School of Medicine,Cancer Center, Ehime University Hospital
来源：
International Journal of Clinical Oncology | 2014年 / 19卷
关键词：
Hematological nadir; Febrile neutropenia (FN); G-CSF prophylaxis; R-CHOP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：178 / 185
页数：7
相关论文
共 50 条
  • [41] Extending Treatment Intervals of R-CHOP Therapy Might Be Acceptable for Some Patients with Non-indolent Non-Hodgkin's B-cell Lymphoma
    Fujishita, Keigo
    Yasuhisa, Sando
    Oka, Satoshi
    Fujisawa, Yuka
    Machida, Takuya
    Imai, Toshi
    ACTA MEDICA OKAYAMA, 2022, 76 (01) : 17 - 24
  • [42] Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy
    Kim, Tark
    Choi, Sang-Ho
    Kim, Sung-Han
    Jeong, Jin-Yong
    Woo, Jun Hee
    Kim, Yang Soo
    Sung, Heungsup
    Kim, Mi-Na
    Yoon, Dok Hyun
    Suh, Cheolwon
    Lee, Sang-Oh
    ANNALS OF HEMATOLOGY, 2013, 92 (02) : 231 - 238
  • [43] Erratum to: Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma
    Ruth Pettengell
    Hans E. Johnsen
    Pieternella J. Lugtenburg
    Antonio Salar Silvestre
    Ulrich Dührsen
    Francesca G. Rossi
    Matthias Schwenkglenks
    Kate Bendall
    Zsolt Szabo
    Ulrich Jaeger
    Supportive Care in Cancer, 2013, 21 : 653 - 653
  • [44] Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma
    Kikuchi, Misato
    Nakasone, Hideki
    Akahoshi, Yu
    Nakano, Hirofumi
    Ugai, Tomotaka
    Wada, Hidenori
    Yamasaki, Ryoko
    Sakamoto, Kana
    Kawamura, Koji
    Ishihara, Yuko
    Sato, Miki
    Ashizawa, Masahiro
    Terasako-Saito, Kiriko
    Kimura, Shun-ichi
    Yamazaki, Rie
    Kako, Shinichi
    Kanda, Junya
    Nishida, Junji
    Sekiguchi, Naohiro
    Noto, Satoshi
    Kida, Michiko
    Hangaishi, Akira
    Usuki, Kensuke
    Kanda, Yoshinobu
    JOURNAL OF CHEMOTHERAPY, 2015, 27 (02) : 99 - 105
  • [45] R-IPI as a predictor of survival in patients with diffuse large cell B-cell lymphoma (DLBCL) treated with R-chop chemotherapy
    Siddiqui, M.
    Johnston, P. B.
    Micallef, I. N.
    Ansell, S. M.
    Colgan, J. P.
    Habermann, T. M.
    Inwards, D. J.
    Markovic, S. N.
    Ristow, K.
    Witzig, T. E.
    Porrata, L. F.
    ANNALS OF ONCOLOGY, 2008, 19 : 146 - 146
  • [46] Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy
    Tark Kim
    Sang-Ho Choi
    Sung-Han Kim
    Jin-Yong Jeong
    Jun Hee Woo
    Yang Soo Kim
    Heungsup Sung
    Mi-Na Kim
    Dok Hyun Yoon
    Cheolwon Suh
    Sang-Oh Lee
    Annals of Hematology, 2013, 92 : 231 - 238
  • [47] Biomarker Analysis in a Phase Ib Study Combining Ibrutinib with R-CHOP in Patients with CD20-Positive B-Cell Non-Hodgkin Lymphoma (NHL)
    Chaturvedi, Shalini
    Schaffer, Michael
    Davis, Cuc
    Aquino, Regina
    Stepanchick, Emily
    Oki, Yasuhiro
    Fourneau, Nele
    Younes, Anas
    Balasubramanian, Sriram
    BLOOD, 2014, 124 (21)
  • [48] Cost-effectiveness analysis of G-CSF in elderly patients with aggressive non-Hodgkin's lymphoma (NHL) receiving CHOP
    Lyman, GH
    Cosler, LE
    VALUE IN HEALTH, 2006, 9 (03) : A107 - A107
  • [49] Interleukin-2 in combination with R-CHOP in the treatment of B-cell non-Hodgkin's lymphomas
    Sachivko, N.
    Zhavrid, E.
    Baranau, Y.
    Petrovitch, S.
    Zhuravkin, I.
    EJC SUPPLEMENTS, 2009, 7 (02): : 564 - 564
  • [50] Pattern of failure and optimal treatment strategy for primary gastric diffuse large B-cell lymphoma treated with R-CHOP chemotherapy
    Kang, Hye Jin
    Lee, Han Hee
    Jung, Seung-Eun
    Park, Kyung-Sin
    Joo-Hyun, O.
    Jeon, Young-Woo
    Choi, Byung-Ock
    Cho, Seok-Goo
    PLOS ONE, 2020, 15 (09):
12345